120 related articles for article (PubMed ID: 38328848)
1. EXPRESSION PROFILE OF miR-145, -182, -21, -27a, -29b, and -34a IN BREAST CANCER PATIENTS OF YOUNG AGE.
Chekhun V; Borikun T; Mushii O; Zadvornyi T; Martyniuk О; Kashuba E; Bazas V; Hrybach S; Krotevych M; Lyalkin S; Lukianova N
Exp Oncol; 2024 Feb; 45(4):421-431. PubMed ID: 38328848
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer.
Li M; Li Q; Yin Q; Wang Y; Shang JM; Wang LH
Clin Transl Oncol; 2021 Apr; 23(4):709-717. PubMed ID: 33206330
[TBL] [Abstract][Full Text] [Related]
3. Expression Analysis of miR-29b in Malignant and Benign Breast Tumors: A Promising Prognostic Biomarker for Invasive Ductal Carcinoma With a Possible Histotype-Related Expression Status.
Papachristopoulou G; Papadopoulos EI; Nonni A; Rassidakis GZ; Scorilas A
Clin Breast Cancer; 2018 Aug; 18(4):305-312.e3. PubMed ID: 29422258
[TBL] [Abstract][Full Text] [Related]
4. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
5. MiR-27 as a prognostic marker for breast cancer progression and patient survival.
Tang W; Zhu J; Su S; Wu W; Liu Q; Su F; Yu F
PLoS One; 2012; 7(12):e51702. PubMed ID: 23240057
[TBL] [Abstract][Full Text] [Related]
6. Serum MiRNA-27a as potential diagnostic nucleic marker for breast cancer.
Swellam M; Zahran RFK; Ghonem SA; Abdel-Malak C
Arch Physiol Biochem; 2021 Feb; 127(1):90-96. PubMed ID: 31145011
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
Orangi E; Motovali-Bashi M
Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
[TBL] [Abstract][Full Text] [Related]
9. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
10. [Expression of microRNA-29b in colorectal cancer and its relationship with clinicopathological features].
Ma X; Yuan W; Tang WY; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):430-3. PubMed ID: 27346400
[TBL] [Abstract][Full Text] [Related]
11. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
[TBL] [Abstract][Full Text] [Related]
13. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.
Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N
Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713
[TBL] [Abstract][Full Text] [Related]
14. KCNQ1OT1 affects cell proliferation, invasion, and migration through a miR-34a / Notch3 axis in breast cancer.
Ren Z; Xu Y; Wang X; Ren M
Environ Sci Pollut Res Int; 2022 Apr; 29(19):28480-28494. PubMed ID: 34993814
[TBL] [Abstract][Full Text] [Related]
15. High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.
Tokumaru Y; Katsuta E; Oshi M; Sporn JC; Yan L; Le L; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357442
[TBL] [Abstract][Full Text] [Related]
16. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
[TBL] [Abstract][Full Text] [Related]
17. Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
Shaker O; Maher M; Nassar Y; Morcos G; Gad Z
Gene; 2015 Apr; 560(1):77-82. PubMed ID: 25644077
[TBL] [Abstract][Full Text] [Related]
18. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.
Li Y; Tian Z; Tan Y; Lian G; Chen S; Chen S; Li J; Li X; Huang K; Chen Y
Mol Cancer; 2020 Jun; 19(1):109. PubMed ID: 32580736
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a Inhibition of the TLR Signaling Pathway Via CXCL10 Suppresses Breast Cancer Cell Invasion and Migration.
Xu M; Li D; Yang C; Ji JS
Cell Physiol Biochem; 2018; 46(3):1286-1304. PubMed ID: 29689563
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer.
Inoue A; Yamamoto H; Uemura M; Nishimura J; Hata T; Takemasa I; Ikenaga M; Ikeda M; Murata K; Mizushima T; Doki Y; Mori M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1410-8. PubMed ID: 25472644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]